Treatment patterns following first-line pertuzumab plus trastuzumab in patients with HER2+metastatic breast cancer in the United States.

被引：1
|
作者：
Mehta, Sandhya
Pavilack, Melissa
Xie, Jipan
Ionescu-Ittu, Raluca
Nie, Xiaoyu
Lei, Yin
Kwong, Jackie
机构：
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] AstraZeneca US, Hlth Econ & Outcomes Res, Gaithersburg, MD USA
[3] Anal Grp Inc, Los Angeles, CA USA
[4] Grp Anal Ltee, Montreal, PQ, Canada
[5] Daiichi Sankyo, Basking Ridge, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18746
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18746
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Effectiveness of Trastuzumab in First-Line HER2+Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study
    Negri, Eva
    Zambelli, Alberto
    Franchi, Matteo
    Rossi, Marta
    Bonifazi, Martina
    Corrao, Giovanni
    Moja, Lorenzo
    Zocchetti, Carlo
    La Vecchia, Carlo
    ONCOLOGIST, 2014, 19 (12): : 1209 - 1215
  • [22] Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer
    Stefanou, Dimitra
    Kokkali, Stefania
    Tripodaki, Elli-Sophia
    Drizou, Maria
    Magou, Elpida
    Zylis, Dimosthenis
    Prevezanou, Maria
    Kapiris, Matthaios
    Nasi, Despoina
    Ntokou, Anna
    Dede, Mary
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2018, 38 (11) : 6565 - 6569
  • [23] Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer
    Ferraro, Emanuela
    Khan, Atif
    Plitas, George
    Chen, Yuan
    Ahmed, Mehnaj
    An, Julia
    Dang, Chau
    Robson, Mark
    Chandarlapaty, Sarat
    Modi, Shanu
    Razavi, Pedram
    Shen, Sherry
    CANCER RESEARCH, 2024, 84 (09)
  • [24] Treatment patterns and associated outcomes among patients with HER2+metastatic breast cancer in the United States: an observational cohort study
    Lam, Clara
    Varghese, Della
    Collins, Jenna
    Nordstrom, Beth
    Murphy, Brian
    Mehta, Sandhya
    Faherty, Eleanor
    ONCOLOGIST, 2025, 30 (04):
  • [25] Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib plus paclitaxel vs trastuzumab plus paclitaxel as first-line treatment for HER2+metastatic breast cancer (NEfERTT)
    Awada, Ahmad
    Colomer, Ramon
    Bondarenko, Igor
    Inoue, Kenichi
    Badwe, Rajendra A.
    Demetriou, Georgia
    Wang, Xiaojia
    Smirnov, Vitaly
    Lee, Soo-Chin
    Mehta, Ajay O.
    Kim, Sung-Bae
    Shen, Zhen-Zhou
    Bachelot, Thomas Denis
    Goswami, Chanchal
    Deo, S. V. S.
    Bose, Ron
    Wong, Alvin
    Xu, Feng
    Bryce, Richard
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Study of the combination gemcitabine and trastuzumab in the treatment of HER2+metastatic breast cancer
    Menjon-Beltran, S.
    Olivencia-Dueso, R.
    Gonzalez-Jimenez, E.
    Titos, M. J.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [27] Advances in First-Line Treatment for Patients with HER-2+ Metastatic Breast Cancer
    De Mattos-Arruda, Leticia
    Cortes, Javier
    ONCOLOGIST, 2012, 17 (05): : 631 - 644
  • [28] Cost-effectiveness of pertuzumab in HER2+metastatic breast cancer
    Qian, Y.
    Durkee, B. Y.
    Pollom, E. L.
    King, M.
    Dudley, S. A.
    Shaffer, J. B.
    Chang, D. T.
    Gibbs, I. C.
    Goldhaber-Fiebert, J. D.
    Horst, K. C.
    CANCER RESEARCH, 2016, 76
  • [29] Effectiveness of trastuzumab in first-line HER2+metastatic breast cancer after failure in adjuvant setting: A controlled cohort study.
    Negri, Eva
    Zambelli, Alberto
    Franchi, Matteo
    Rossi, Marta
    Bonifazi, Martina
    Corrao, Giovanni
    Zambon, Antonella
    Moja, Lorenzo
    Zocchetti, Carlo
    La Vecchia, Carlo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs
    Suleman, Kausar
    Mushtaq, Ali Hassan
    Haque, Emaan
    Badran, Ahmed Ali
    Ajarim, Dahish
    Elashwah, Ahmed Mohammed
    Gad, Ahmed Mostafa
    Abdelsamad, Amgad Shaheen
    Omar, Ayman
    Khan, Khurshid Ahmed
    Al-Tweigeri, Taher
    Elshentenawy, Ayman
    Alsayed, Adher
    BREAST CARE, 2021, 16 (01) : 59 - 65
12345